These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38162493)

  • 1. Corrigendum: Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma.
    Xie S; Wang M; Zeng C; Ou Y; Zhao L; Wang D; Chen L; Kong F; Yi D
    Front Oncol; 2023; 13():1338060. PubMed ID: 38162493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corrigendum: Advanced lung cancer inflammation index predicts survival outcomes of hepatocellular carcinoma patients receiving immunotherapy.
    Li Q; Ma F; Wang JF
    Front Oncol; 2024; 14():1431058. PubMed ID: 38915365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum: Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: a systematic review and meta-analysis.
    Liu JN; Li JJ; Yan S; Zhang GN; Yi PS
    Front Oncol; 2023; 13():1233247. PubMed ID: 37427117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum: Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy [Corrigendum].
    J Hepatocell Carcinoma; 2024; 11():563-564. PubMed ID: 38504850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum: Effects of alkalization therapy on hepatocellular carcinoma: a retrospective study.
    Isowa M; Hamaguchi R; Narui R; Morikawa H; Wada H
    Front Oncol; 2023; 13():1291026. PubMed ID: 37799473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum: Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer.
    Peng Y; Li Z; Fu Y; Pan Y; Zeng Y; Liu J; Xiao C; Zhang Y; Su Y; Li G; Wu F
    Front Oncol; 2023; 13():1163376. PubMed ID: 37064096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum: Salivary Gland Carcinoma: Novel Targets to Overcome Treatment Resistance in Advanced Disease.
    Di Villeneuve L; Souza IL; Tolentino FDS; Ferrarotto R; Schvartsman G
    Front Oncol; 2021; 11():669486. PubMed ID: 33898325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum: Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma.
    Zhang K; Liu H; Yu M; Zhao H; Yang N; Bi X; Sun L; Lin R; Lü G
    Front Oncol; 2021; 11():785394. PubMed ID: 34722323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma.
    Hu X; Bao M; Huang J; Zhou L; Zheng S
    Front Oncol; 2020; 10():617539. PubMed ID: 33330112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum: CDT1 is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma.
    Cai C; Zhang Y; Hu X; Hu W; Yang S; Qiu H; Chu T
    Front Oncol; 2021; 11():801970. PubMed ID: 34900749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum: Oncolytic Adenovirus-A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC.
    Abudoureyimu M; Lai Y; Tian C; Wang T; Wang R; Chu X
    Front Oncol; 2020; 10():701. PubMed ID: 32432043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum: Fat fraction quantification with MRI estimates tumor proliferation of hepatocellular carcinoma.
    Huang M; Zhang F; Li Z; Luo Y; Li J; Wang Z; Ma L; Chen G; Hu X
    Front Oncol; 2024; 14():1418905. PubMed ID: 38841171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum: Review of novel functions and implications of circular RNAs in hepatocellular carcinoma.
    Liu Z; Yang F; Xiao Z; Liu Y
    Front Oncol; 2024; 14():1380699. PubMed ID: 38469230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum: High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma.
    Wang X; Xing Z; Chen H; Yang H; Wang Q; Xing T
    Front Oncol; 2023; 13():1134139. PubMed ID: 37025598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum: Prediction of Microvascular Invasion and Its M2 Classification in Hepatocellular Carcinoma Based on Nomogram Analyses.
    Chen S; Wang C; Gu Y; Ruan R; Yu J; Wang S
    Front Oncol; 2022; 12():888008. PubMed ID: 35449582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum: SPOCK1 promotes the development of hepatocellular carcinoma.
    Váncza L; Karászi K; Péterfia B; Turiák L; Dezső K; Sebestyén A; Reszegi A; Petővári G; Kiss A; Schaff Z; Baghy K; Kovalszky I
    Front Oncol; 2023; 13():1203745. PubMed ID: 37152016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum: Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma.
    Che L; Paliogiannis P; Cigliano A; Pilo MG; Chen X; Calvisi DF
    Front Oncol; 2022; 12():874053. PubMed ID: 35494002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum: A genome-wide investigation of effects of aberrant DNA methylation on the usage of alternative promoters in hepatocellular carcinoma.
    Dong Y; Liu X; Jiang B; Wei S; Xiang B; Liao R; Wang Q; He X
    Front Oncol; 2023; 13():1253552. PubMed ID: 37719011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum: YY1 Promotes Endothelial Cell-Dependent Tumor Angiogenesis in Hepatocellular Carcinoma by Transcriptionally Activating VEGFA.
    Yang W; Li Z; Qin R; Wang X; An H; Wang Y; Zhu Y; Liu Y; Cai S; Chen S; Sun T; Meng J; Yang C
    Front Oncol; 2021; 11():828861. PubMed ID: 35096629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrigendum: Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma.
    Lai Y; Feng B; Abudoureyimu M; Zhi Y; Zhou H; Wang T; Chu X; Chen P; Wang R
    Front Oncol; 2020; 10():277. PubMed ID: 32195187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.